|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Non-Small Cell Lung Cancer - Despite global efforts to stop smoking, incidence rates will remain unchanged
Datamonitor, Nov 2011, Pages: 48
Smoking is the leading cause of lung cancer, responsible for 95% of all cases. Global efforts to stop smoking have stabilized over the last decade. Datamonitor epidemiologists expect the number of total incident cases of non-small cell lung carcinoma to remain stable in the seven major markets over the next 10 years.
Features and benefits
- Gain insight into market potential, including a robust 10-year epidemiology forecast of non-small cell lung cancer.
- Understand the key epidemiologic risk factors associated with non-small cell lung cancer.
Highlights
- Most people are not diagnosed with lung cancer until the disease has advanced to later-stage illness, making it difficult to treat the cancer successfully and greatly impacting 5-year survival rates for the disease. Smoking cessation is the most effective measure in reducing the risk of non-small cell lung cancer.
- For newly diagnosed non-small cell lung cancer in the seven major markets, adults aged 70–74 will have the largest number of total incident cases (80,310 cases), followed by adults ages 65–69 and 75–79 (73,500 cases and 71,300 cases, respectively).
Your key questions answered
- What are the most robust sources for non-small cell lung cancer incidence data?
- How will the patient population change through to 2020 in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the trend in incident non-small cell lung cancer cases?
|
|
|
|
